Privacy Policy & Terms and Conditions

Last Updated: July 7th, 2026

Introduction

NeuxScience® is a trademarked specialised software as a service platform of Neux Ltd, designed for the computational modelling of working memory, executive functions, and related higher order cognitive constructs. The platform enables researchers to build, simulate, and empirically validate cognitive architectures, which may then be deployed as adaptive cognitive interventions or high precision assessment tools, with integration across EEG and VR based research environments.

These Terms and Conditions (the “Terms”) govern the access to and use of NeuxScience® (the “Platform”). By accessing or using the Platform, whether as a researcher, clinician, institutional user, study participant, or client organisation, you agree to be bound by these Terms. If you are entering into these Terms on behalf of an organisation, you represent and warrant that you have the authority to bind that organisation to these Terms.

Definitions

“Account” means the user account created to access the Platform.

“Agreement” means these Terms together with any applicable subscription agreement, data processing agreement, or other written agreement between the Company and the Subscribing Organisation.

“Client Organisation” means any organisation that has entered into a subscription agreement with the Company for access to the Platform.

“Content” means any data, information, models, simulations, tasks, assessments, interventions, or other materials submitted, uploaded, or generated through the Platform.

“EEG” means electroencephalography.

“Higher Order Cognitive Constructs” means working memory, executive functions, cognitive control, decision making, and related neurocognitive processes.

“Intellectual Property Rights” means patents, copyrights, trademarks, trade secrets, database rights, and all other proprietary rights.

“Personal Data” has the meaning set out in the Privacy Policy.

“Platform” means the NeuxScience® software as a service platform.

“Subscribing Organisation” means any organisation that has entered into a subscription agreement with the Company.

“Subscription” means the paid or trial access to the Platform.

“VR” means virtual reality.

“User” means any individual accessing or using the Platform, whether as a researcher, clinician, study participant, or otherwise.

  1. Account Registration and Access

1.1 Account Creation. To access the Platform, Users must create an Account by providing accurate, complete, and current Registration Data as set out in the Privacy Policy.

1.2 Account Security. Users are responsible for maintaining the confidentiality of their Account credentials and for all activities that occur under their Account. Users must notify the Company immediately of any unauthorised access or security breach.

1.3 Eligibility. The Platform is intended for use by researchers, clinicians, and institutions engaged in legitimate scientific research. Users must be at least 18 years of age.

1.4 User Roles. The Platform supports multiple user roles with different access permissions. Users may only access features and data appropriate to their assigned role.

  1. Platform Functionality

2.1 Core Services. The Platform provides the following core services:

  • Design and deployment of cognitive tasks and experimental paradigms
  • Collection of behavioural performance metrics and neurophysiological data (EEG and VR)
  • Computational modelling and simulation of cognitive architectures
  • Empirical validation of cognitive models
  • Deployment of adaptive cognitive interventions and assessment tools

2.2 Integration. The Platform supports integration with EEG equipment and VR environments. Users are responsible for ensuring compatibility of their hardware with the Platform specifications.

2.3 Service Availability. The Company uses reasonable endeavours to maintain the Platform’s availability. Scheduled maintenance shall be notified to Users in advance where reasonably practicable.

  1. Subscriptions and Payment

3.1 Subscription Fees. Access to the Platform requires a valid Subscription. Fees are set out in the applicable subscription agreement.

3.2 Payment Terms. Fees are payable in accordance with the terms set out in the subscription agreement. Late payments may result in suspension of access.

3.3 Trial Access. The Company may offer trial access to the Platform. Trial access is subject to these Terms and any additional terms specified at the time of trial registration.

  1. Intellectual Property

4.1 Company Intellectual Property. The Platform, including its software, user interface, documentation, and underlying technology, is the exclusive property of the Company and is protected by Intellectual Property Rights. Users are granted a non-exclusive, non-transferable, revocable right to access and use the Platform during the term of their Subscription.

4.2 User Ownership. Users retain full ownership of all intellectual property they create using the Platform, including but not limited to cognitive architectures, algorithms, models, simulations, tasks, experimental paradigms, and research data. The Company claims no ownership over User-generated content or intellectual property.

4.3 Licence to Company. By submitting Content to the Platform, Users grant the Company a non-exclusive, royalty-free, worldwide licence to use, reproduce, and store the Content solely for the purpose of providing the Platform services and for anonymised research and analytical purposes as set out in the Privacy Policy. This licence does not extend to the underlying algorithms, models, or intellectual property created by the User.

4.4 Anonymisation. The Company may anonymise Content for research and analytical purposes. Anonymised data may be used by the Company as set out in the Privacy Policy.

4.5 Prohibited Use. Users may not reverse engineer, decompile, or disassemble any part of the Platform; copy, modify, or create derivative works of the Platform; or use the Platform for any purpose other than legitimate scientific research.

  1. Data Protection

5.1 Privacy Policy. The processing of Personal Data is governed by the Privacy Policy, which forms part of these Terms.

5.2 Data Security. The Company implements appropriate technical and organisational security measures to protect Content and Personal Data.

5.3 Research Participant Data. Where Users collect data from research participants, Users are responsible for obtaining all necessary ethics approvals and informed consents.

5.4 Data Processing Agreement. Where the Company processes Personal Data on behalf of a Client Organisation as a data processor, a separate data processing agreement shall apply.

  1. User Obligations

6.1 Lawful Use. Users shall use the Platform only for lawful purposes and in compliance with all applicable laws, regulations, and research ethics standards.

6.2 Ethical Research. Users are responsible for obtaining all required ethics approvals for their research, including approvals for studies involving human participants, EEG, or VR interventions.

6.3 Informed Consent. Users are responsible for obtaining informed consent from research participants. Users must ensure that participants are informed about the collection, processing, and anonymisation of their data.

6.4 Prohibited Activities. Users shall not:

  • Use the Platform to store, process, or transmit any unlawful, defamatory, or harmful content
  • Attempt to gain unauthorised access to the Platform or any other user’s Account
  • Interfere with or disrupt the Platform or its underlying infrastructure
  • Use the Platform to infringe the Intellectual Property Rights of any third party
  • Use the Platform for any clinical or diagnostic purposes without appropriate regulatory approvals

  1. Disclaimer and Limitation of Liability

7.1 Research Use Only. The Platform is provided for research purposes only. Unless expressly agreed in writing, the Platform is not intended for clinical diagnostic, therapeutic, or regulatory submission purposes.

7.2 No Warranty. The Platform is provided “as is” and “as available”. To the maximum extent permitted by law, the Company makes no warranties, express or implied, including warranties of merchantability, fitness for a particular purpose, or non-infringement. The Company does not warrant that the Platform will be error-free, uninterrupted, or secure.

7.3 Limitation of Liability. To the maximum extent permitted by law, the Company shall not be liable for any indirect, incidental, special, consequential, or punitive damages, including loss of data, loss of profits, or loss of research, arising out of or in connection with the use of the Platform. The Company’s total liability for all claims arising under these Terms shall not exceed the total fees paid by the Subscribing Organisation in the twelve months preceding the claim.

7.4 Research Outcomes. The Company is not responsible for the validity, accuracy, or reliability of any research outcomes or conclusions derived from use of the Platform. Users are solely responsible for the interpretation and validation of their research data.

  1. Indemnification

Users agree to indemnify, defend, and hold harmless the Company, its directors, officers, employees, and agents from and against any claims, liabilities, damages, losses, costs, or expenses arising out of: (a) the User’s use of the Platform in violation of these Terms; (b) any violation of applicable laws or research ethics standards; (c) any claim that User Content infringes third-party rights; or (d) any clinical or regulatory use of the Platform without express authorisation.

  1. Termination

9.1 Termination by User. Users may terminate their Account at any time by contacting the Company.

9.2 Termination by Company. The Company may terminate or suspend access to the Platform immediately if the User: (a) breaches these Terms; (b) uses the Platform in an unlawful or unethical manner; or (c) fails to pay subscription fees when due.

9.3 Effect of Termination. Upon termination: (a) access to the Platform shall cease; (b) Users may export their Content as specified in the subscription agreement; (c) Personal Data shall be deleted or anonymised as set out in the Privacy Policy; and (d) any provision of these Terms which by its nature should survive termination shall remain in effect.

  1. Modifications to the Platform

The Company reserves the right to modify, update, or discontinue any feature of the Platform, including functionality, interfaces, and integrations. The Company shall use reasonable endeavours to notify Users of material changes that affect core functionality.

  1. Modifications to These Terms

The Company reserves the right to update these Terms from time to time. The updated version shall be indicated by an updated “Last Updated” date at the top of these Terms. Material changes shall be notified to Users via the Platform or by email. Continued use of the Platform following such notification shall constitute acceptance of the amended Terms.

  1. Governing Law

These Terms shall be governed by and construed in accordance with the laws of England and Wales. The courts of England and Wales shall have exclusive jurisdiction over any dispute arising out of or in connection with these Terms.

  1. General

13.1 Entire Agreement. These Terms, together with the Privacy Policy and any applicable subscription agreement, constitute the entire agreement between the parties.

13.2 Severability. If any provision of these Terms is held to be invalid or unenforceable, the remaining provisions shall remain in full force and effect.

13.3 Waiver. No failure or delay in exercising any right under these Terms shall constitute a waiver of that right.

13.4 Assignment. Users may not assign or transfer their rights under these Terms without the prior written consent of the Company. The Company may assign or transfer these Terms to any successor entity.

13.5 Notices. Notices shall be sent to the email address associated with the User’s Account or to the address set out below.

  1. Contact Information

For any questions, notices, or requests regarding these Terms, please contact:

Neux Ltd
86–90 Paul Street
London, EC2A 4NE
United Kingdom
Email: dorota@neuxscience.com